JPMorgan Chase & Co’s Neos Therapeutics, Inc NEOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-14
| Closed | – | – | 5170 |
|
|
2020
Q2 | $0 | Buy |
+14
| New | – | ﹤0.01% | 5100 |
|
|
2020
Q1 | – | Sell |
-95,590
| Closed | -$144K | – | 4936 |
|
|
2019
Q4 | $144K | Buy |
95,590
+90,696
| +1,853% | +$137K | ﹤0.01% | 3924 |
|
|
2019
Q3 | $7K | Sell |
4,894
-211,006
| -98% | -$302K | ﹤0.01% | 4612 |
|
|
2019
Q2 | $261K | Buy |
215,900
+204,481
| +1,791% | +$247K | ﹤0.01% | 3661 |
|
|
2019
Q1 | $30K | Sell |
11,419
-25,400
| -69% | -$66.7K | ﹤0.01% | 4398 |
|
|
2018
Q4 | $61K | Sell |
36,819
-230,598
| -86% | -$382K | ﹤0.01% | 4205 |
|
|
2018
Q3 | $1.3M | Buy |
267,417
+165,555
| +163% | +$803K | ﹤0.01% | 3014 |
|
|
2018
Q2 | $636K | Buy |
101,862
+96,879
| +1,944% | +$605K | ﹤0.01% | 3344 |
|
|
2018
Q1 | $41K | Sell |
4,983
-610
| -11% | -$5.02K | ﹤0.01% | 4220 |
|
|
2017
Q4 | $57K | Sell |
5,593
-8,156
| -59% | -$83.1K | ﹤0.01% | 4091 |
|
|
2017
Q3 | $120K | Buy |
+13,749
| New | +$120K | ﹤0.01% | 3595 |
|
|
2017
Q2 | – | Sell |
-13,681
| Closed | -$99K | – | 4607 |
|
|
2017
Q1 | $99K | Buy |
13,681
+4,120
| +43% | +$29.8K | ﹤0.01% | 3736 |
|
|
2016
Q4 | $56K | Buy |
+9,561
| New | +$56K | ﹤0.01% | 4002 |
|